Astragalus
Best-in-class: Astragalus
A foundational adaptogenic immune herb in Chinese medicine, studied for immune modulation, kidney/cardiovascular support and (via cycloastragenol) telomere/longevity interest.
Astragalus quick facts
| Suggested dose | 500–1,000 mg extract daily. |
| How often | Daily |
| Who it's for | Immune resilience and longevity-minded support. |
Used as an adjuvant in Chinese oncology with meta-analysis support for reduced chemotherapy toxicity and improved response, which is more clinical evidence than most immune herbs have. Because it stimulates rather than modulates, it is a poor choice in autoimmunity and after transplant. Traditionally used preventively rather than during acute illness.
How Astragalus actually works
Polysaccharides and saponins that increase T-cell and NK-cell activity, with astragaloside IV as a characterized active. It is also the source of cycloastragenol, the telomerase activator, though ordinary astragalus extracts contain very little of it.
Where to get Astragalus
Find Astragalus on iHerb →The evidence for Astragalus
Graded by what exists behind each claim.
✅ Clinically validated
- Supports immune function and has RCT support as an adjunct in various conditions (kidney, cardiovascular).
- Cycloastragenol/astragaloside are studied for telomerase activation.
📊 Correlative data
- Traditional immune-tonic use aligns with the immunomodulatory findings.
🧪 Theoretical / extrapolated benefits
- Telomere-lengthening/longevity claims are exciting but come mostly from cell studies and expensive isolated fractions.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Astragalus actually does
Two completely different chemistries are sold under one root, and almost every confused claim about astragalus comes from letting them share a name.
Chemistry one: the polysaccharide. Astragalus polysaccharide is a glucan-heteroglycan fraction, and its immunological receptor is not Dectin-1. It signals through TLR4 and the MyD88-dependent pathway, raising TNF-alpha, IL-1beta and IL-6 in cells and in mice Zhou 2017. Worth stopping on that: TLR4 is the lipopolysaccharide receptor, the sensor the innate system uses to detect Gram-negative bacteria. A plant polysaccharide reported to act on the endotoxin receptor has a live alternative explanation — endotoxin carried along with the polysaccharide — and the polymyxin B controls that would exclude it are absent from most of this literature.
Chemistry two: the saponins. Astragaloside IV is a cycloartane triterpene glycoside, and cycloastragenol is its aglycone — the sugar removed. Cycloastragenol is the molecule behind the telomerase story and behind the expensive products Harley 2011. It is a small lipophilic triterpene with nothing in common, chemically or mechanistically, with the polysaccharide above.
And the saponin barely gets in. Astragaloside IV given orally to rats had an absolute bioavailability of 2.2%, with a measured permeability of 6.7 ± 1.0 × 10-8 cm/sec across Caco-2 monolayers Gu 2004. That is the pure compound, given deliberately, in an animal. It bounds what any root capsule can deliver, and it is the number the longevity marketing never reaches for.
Cell, rodent, human — and where it stops
Cells and mice. Astragalus polysaccharide acting through TLR4-MyD88, cytokines up, tumor apoptosis increased, in vitro and in vivo Zhou 2017.
The largest human evidence base, and it is not about immunity. A Cochrane review of astragalus in chronic kidney disease pooled 22 studies in 1,323 participants: proteinuria reduced, hemoglobin raised, effects on kidney function inconsistent Zhang 2014. That is the biggest, best-organized body of clinical data this plant has, and it belongs to people with a diagnosed kidney disease.
The telomere trials, which are about a different molecule. In an open program, TA-65 at 10–50 mg daily was associated with a decline in senescent CD8+/CD28− T cells at 6 to 12 months in CMV-positive subjects Harley 2011. A subsequent randomized, double blind, placebo-controlled study in 117 CMV-positive people aged 53 to 87 reported telomere length rising by 530 ± 180 base pairs over 12 months on low-dose TA-65 against a loss of 290 ± 100 base pairs on placebo, p = 0.005 Salvador 2016.
The obstacle is two of the three at once. Population: the kidney data is in kidney patients Zhang 2014, and the telomere trials deliberately enrolled CMV-positive older adults, because that is the group in whom senescent T cells accumulate Harley 2011. Form: the telomere result belongs to a purified activator dosed in milligrams Salvador 2016, not to 500 mg of root extract, and the root's own marker saponin reaches 2.2% oral bioavailability in a rat Gu 2004.
And the use that sells it has no trial at all. There is no randomized study of astragalus root extract for respiratory infection incidence in healthy adults.
Astragalus — which form, and does it matter
Root extract and cycloastragenol are not the same product at different prices. The published TA-65 dose is 10–50 mg of a purified activator Harley 2011. A shelf bottle is 500–1,000 mg of root extract carrying no stated quantity of cycloastragenol at all. You cannot compare them, because one side of the comparison is a blank on the label.
Standardization, when it exists, is to the wrong molecule for the longevity claim. Astragaloside IV standardization (commonly quoted as a fraction of a percent) tells you about the glycoside, and the telomerase interest belongs to its aglycone. Converting one to the other requires hydrolysis, which is a manufacturing step, not something a stomach reliably does.
Species identity is a real risk here and not a formality. The genus Astragalus contains species that accumulate selenium and species associated with swainsonine — the locoweeds. This is a botanical-identity problem rather than a dosing one, and the mitigation is buying Astragalus membranaceus from a supplier who tests identity, not buying a bigger capsule.
Ask what the kidney studies gave. The Cochrane pooling covers a heterogeneous set of astragalus preparations Zhang 2014, and preparation is exactly the variable a person converting that evidence into a purchase needs to know. Where a review's own conclusion is limited by study quality, importing its result onto a capsule is a bigger leap than it looks.
What would have to be true, and how you would know it was not
1. The prediction that cuts hardest against the product. Predict leukocyte telomere length does not change measurably on 500–1,000 mg/day of root extract over 12 months. The trial that moved telomeres used a purified activator Salvador 2016, the effect it reported was 530 base pairs, and the run-to-run variability of commercial telomere assays is of the same order as a year of natural attrition. If you are buying the root for telomeres, this is the prediction to try to break, and breaking it would be a genuinely new result.
2. The prediction where the mechanism working looks like the thing you did not want. If astragalus polysaccharide is doing anything systemically through TLR4-MyD88 Zhou 2017, the signature is innate cytokine output, and the accessible proxy is hs-CRP. Predict hs-CRP stays flat at label doses. A rise would mean the endotoxin-receptor pathway is running in you — which is the mechanism advertised, and is not obviously an outcome anyone should want to buy.
3. The clinical endpoint, named as a clinician's. In chronic kidney disease the readouts with pooled support are urine protein and hemoglobin Zhang 2014. Those are ordered and interpreted by a nephrologist, and a person with kidney disease self-directing a herb on the strength of a Cochrane review has skipped the part where the review says the effects on kidney function were inconsistent.
What will fool you: the assay itself. Two telomere measurements six months apart from a consumer service can differ by more than the effect being chased. Run the same laboratory, the same method, and ideally duplicate samples, or you are measuring the laboratory.
What nobody has tested yet
Nobody has measured serum astragaloside IV after a root-extract capsule. The pure compound reaches 2.2% oral bioavailability in a rat Gu 2004; what fraction of that arrives from a 500 mg root extract in a person has never been published. Until it is, nobody can say whether the pharmacologically studied molecule is in the blood at all.
The endotoxin control has not been run. Repeating the TLR4-MyD88 experiments Zhou 2017 with polymyxin B, or with endotoxin-depleted polysaccharide, would separate a genuine plant-polysaccharide signal from contamination. It is a standard control in innate immunology and it is largely missing from this literature.
Root extract against purified cycloastragenol, on one shared readout. Senescent CD8+/CD28− T cell fraction by flow cytometry would do it Harley 2011. Nobody has run it, and its absence is why the cheap product can market on the expensive one's data.
And the obvious trial has never happened. Astragalus root extract against placebo in healthy adults across a winter, counting respiratory infections. That is the use, and there is no study of it.
Astragalus — its own safety story, not its category's
The ciclosporin interaction is the documented one, and it compounds with the immune claim. A transplant recipient adding astragalus is adding a product whose proposed action is raising innate cytokine output through TLR4 Zhou 2017 on top of a regimen designed to suppress exactly that, and doing so alongside a reported interaction with the drug holding the graft. There is no version of that combination worth the risk.
The identity risk is specific to this genus. Some Astragalus species are toxic and some accumulate selenium. This is a reason to care about the supplier rather than the dose, and it is unlike almost every other product on this shelf, where the plant is at least unambiguous.
Glucose and blood pressure both drift downward. Additive with medication for either. Pregnancy is an avoid on absence of data.
No upper limit exists and the longest controlled exposure is not of this product. Twelve months of a purified telomerase activator Salvador 2016 is the longest randomized human exposure in this family, and it is a different molecule at a different dose. For the root extract itself, exposure beyond the trial durations in the kidney literature Zhang 2014 is undocumented.
Who should not take it: transplant recipients, people on ciclosporin or other calcineurin inhibitors, and anyone with an autoimmune disease who has not thought about the TLR4 mechanism above — because that receptor is the innate system's alarm, and the product is sold on pulling it.
Sources read for this page
- Zhou L, Liu Z, et al. Astragalus polysaccharides exerts immunomodulatory effects via TLR4-mediated MyD88-dependent signaling pathway in vitro and in vivo. Scientific Reports 2017 · PMID 28303957
- Gu Y, et al. Transport and bioavailability studies of astragaloside IV, an active ingredient in Radix Astragali. Basic & Clinical Pharmacology & Toxicology 2004 · PMID 15569275
- Zhang HW, Lin ZX, et al. Astragalus (a traditional Chinese medicine) for treating chronic kidney disease. Cochrane Database of Systematic Reviews 2014 · PMID 25335553
- Harley CB, et al. A natural product telomerase activator as part of a health maintenance program. Rejuvenation Research 2011 · PMID 20822369
- Salvador L, et al. A Natural Product Telomerase Activator Lengthens Telomeres in Humans: A Randomized, Double Blind, and Placebo Controlled Study. Rejuvenation Research 2016 · PMID 26950204
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: Infections, counted. Days off work, courses of antibiotics, and the number of separate respiratory episodes across a fall and winter, set against the same count for the year before. A tonic's only honest claim is that fewer things happen, which means you have to have been counting before you started.
- How long before it means anything: A season at minimum, and ideally next to a record of the previous one. Three weeks of an immune herb during which you did not get sick is not evidence; most three-week stretches contain no illness at all.
- What will fool you: Two things. The calendar first: everyone starts an immune herb in October and everyone has fewer colds by May, so an uncontrolled year always ends with the herb looking good. The second is the telomere marketing that rides along with this plant — those claims belong to cycloastragenol, a different and far more expensive product, and nothing about the cheap root extract has been shown to lengthen anything.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Astragalus — safety & side effects
- Generally well tolerated; GI upset is the main report.
- Immunostimulant — caution with autoimmune disease and with immunosuppressants, including after a transplant. Stimulating an immune system that is already attacking you is the wrong direction, and 'natural' does not change that. It has a documented interaction with ciclosporin.
- May lower blood glucose and blood pressure. Avoid in pregnancy. Some species of astragalus are toxic — buy *Astragalus membranaceus* from a reputable source.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Astragalus in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Astragalus
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| Complete Blood Count (CBC) with Differential | White cells and their differential — the actual immune measurement |
| Vitamin D (25-Hydroxy) | The deficiency with the most credible immune evidence |
| Zinc, Plasma | Real deficiency impairs immune function; excess doesn't help |
| Comprehensive Metabolic Panel (CMP) | Liver and kidney, since 'detox' is what those two organs do |
The Frequent Illness & Immune Resilience panel covers these in one order — 8 markers, $97.65 with the discount applied.
Check results you already have → · All 103 markers A–Z
Astragalus — frequently asked questions
What is Astragalus?
A foundational adaptogenic immune herb in Chinese medicine, studied for immune modulation, kidney/cardiovascular support and (via cycloastragenol) telomere/longevity interest.
What is the suggested dose of Astragalus?
500–1,000 mg extract daily. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Astragalus dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Astragalus?
Coach Cam sources Astragalus from vetted, top-rated brands on iHerb — use the buy link on this page.
What Astragalus is used for
Astragalus appears under 1 goal in the goal router.
Related Immune & Detox supplements
Where this goes next
The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.